Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome

Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome

US Patent 9556434 · Granted Jan 31, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense compounds targeting genes associated with cystic fibrosis2024
Compounds and methods for the modulation of amyloid-β precursor protein2023
Antisense compounds targeting genes associated with cystic fibrosis2021
Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatm2020
Antisense compounds targeting genes associated with cystic fibrosis2020
Antisense compounds targeting genes associated with cystic fibrosis2020
Antisense compounds targeting apolipoprotein E receptor 22019
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treat2019
Antisense compounds targeting genes associated with cystic fibrosis2017
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treat2017
Antisense compounds targeting genes associated with usher syndrome2016
Antisense oligonucleotides that target a cryptic splice site in Ush1c as a thera2014